Potassium%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520chloride

# Potassium Chloride ## Overview Potassium chloride (KCl) is an essential electrolyte used to treat and prevent hypokalemia. It is available in oral and intravenous formulations. ## Primary Indications * Treatment and prevention of hypokalemia. * Management of specific types of metabolic alkalosis. ## Adult Dosing * **Oral Replacement:** * **Mild Hypokalemia (3.0-3.5 mEq/L):** 20-40 mEq daily in 1-2 divided doses. * **Moderate Hypokalemia (2.5-3.0 mEq/L):** 40-100 mEq daily in 2-4 divided doses. * **Severe Hypokalemia (<2.5 mEq/L):** Dosing is highly individualized and may require up to 200 mEq daily, often with continuous cardiac monitoring. Administration should be slow and divided. * **Maintenance:** 10-20 mEq daily. * **Maximum oral dose:** Generally not to exceed 100 mEq daily in divided doses without close monitoring. * **Intravenous (IV) Replacement:** * **Mild Hypokalemia:** 10-20 mEq/L in 1 L of IV fluid, infused at a rate not exceeding 10 mEq/hour. * **Moderate Hypokalemia:** 20-40 mEq/L in 1 L of IV fluid, infused at a rate not exceeding 20 mEq/hour, with continuous cardiac monitoring. * **Severe Hypokalemia:** May require higher concentrations (e.g., 40 mEq/L) and faster infusion rates (e.g., up to 40 mEq/hour), *only* in emergent situations, with continuous cardiac monitoring and frequently checked potassium levels. This must be done with extreme caution due to risk of cardiac arrest. * **Maximum IV dose:** Total daily dose should not exceed 200 mEq in 24 hours. Higher doses may be administered in critical care settings, as per local protocol. ## Pediatric Dosing * **Oral Replacement:** * **Mild Hypokalemia:** 2-4 mEq/kg/day in 2-4 divided doses. * **Maximum oral dose:** Generally not to exceed 100 mEq/day. * **Intravenous (IV) Replacement:** * **General:** 0.5-1 mEq/kg/dose infused over 1-3 hours. * **Maximum concentration:** Typically 40 mEq/L. * **Maximum infusion rate:** Typically 10-20 mEq/hour, but can be faster in critical situations with continuous monitoring. * **Maximum daily dose:** Dosing is individualized; often not to exceed 100-200 mEq/day. Specific protocols vary widely. ## Dose Adjustments * **Renal Impairment:** Use with extreme caution. Dose reduction or discontinuation is often necessary. Monitor potassium closely. ## Contraindications * Hyperkalemia. * Conditions associated with hyperkalemia, such as advanced renal failure, untreated Addison's disease, severe burns, or certain types of dehydration. * Potassium-retaining diuretic therapy (unless used cautiously with close monitoring). ## Adverse Effects * **Common:** Nausea, vomiting, diarrhea, abdominal pain. * **Serious:** Hyperkalemia (especially with rapid IV infusion or in patients with renal impairment), cardiac arrhythmias, cardiac arrest, gastrointestinal ulceration or bleeding (with oral forms), phlebitis (with IV administration). ## Key Drug Interactions * **Potassium-Sparing Diuretics (e.g., spironolactone, amiloride, triamterene):** Increased risk of hyperkalemia. * **ACE Inhibitors and ARBs:** Increased risk of hyperkalemia. * **NSAIDs:** May impair potassium excretion, increasing risk of hyperkalemia. * **Salt Substitutes:** Contain high amounts of potassium chloride; use with caution to avoid excessive intake. ## Monitoring * **Serum Potassium:** Essential, especially during IV therapy, dose changes, or in patients with renal impairment. Frequency depends on severity of hypokalemia and clinical status. * **Renal Function (BUN, creatinine):** To assess risk of potassium accumulation. * **ECG:** Particularly important for patients receiving rapid IV potassium or those at high risk for hyperkalemia and arrhythmias. * **Urine Output:** To ensure adequate renal function. ## Clinical Pearls * Oral potassium chloride should be taken with meals or a full glass of water to minimize gastrointestinal irritation. * Dilute concentrated IV potassium chloride solutions appropriately to prevent phlebitis and reduce the risk of rapid potassium infusion. * Never administer potassium chloride as an IV bolus. * Always confirm the concentration and rate of infusion for IV potassium. * In cases of severe hypokalemia or symptomatic hypokalemia, IV administration is preferred, often in an intensive care setting with continuous monitoring. *** *Disclaimer: This information is intended for healthcare professionals. Always consult the most current prescribing information and local protocols for complete details before administering any medication.*